arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Enlivex Ltd.

ENLV Health Care Biotechnology: Pharmaceutical Preparations
$4.58
Today
as of Jul 22, 16:48 ET
Last 30 days -54.38% Jun 12 → Jul 22
$4.15 $5.73 $7.32 $8.90 $10.49 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$0.78
High
$0.78
Low
$0.70
Volume
$307,198
Avg Vol
$1M
Mkt Cap
$80M
P/E (TTM)
—
Beta
—
52w High
$2.10
52w Low
$0.66
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 5 items

Jul 13 · 16:00 Zacks
Enlivex Ltd. (ENLV) Upgraded to Buy: Here's Why
Jul 13 · 13:35 Zacks
Enlivex Ltd. (ENLV) Loses 31.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Jul 13 · 12:33 MT Newswires
Enlivex's Allocetra Receives FDA RMAT Designation for Knee Osteoarthritis
▸ Show all 5 press releases & news Free account →

Overview

52-week range
$0.66
$2.10
100% of range
Avg surprise (last 2)
+28.1%
Avg reaction (last 1)
-0.2%
0% positive
Latest IV / EM
7576%
EM ±894.9% · $3 · Jul 17

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.66$-0.39$-0.12$0.15$0.42 Actual $-0.15Est $-0.16Actual $-0.08Est $-0.16 Mar/2025Jun/2025

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Aug 29, 2025Jun/2025 $-0.08 $-0.16 +50.0% — — earnings
Fri May 30, 2025Mar/2025 $-0.15 $-0.16 +6.2% — -0.2% earnings

Implied volatility — last 90 days

2720%5430%8140%10850%13560% Jun 07 — IV 3661% · EM ±507.0%Jun 08 — IV 3711% · EM ±490.1%Jun 09 — IV 4379% · EM ±548.7%Jun 10 — IV 4657% · EM ±550.1%Jun 11 — IV 4783% · EM ±528.5%Jun 12 — IV 5252% · EM ±537.2%Jun 15 — IV 7749% · EM ±560.5%Jun 16 — IV 9269% · EM ±547.4%Jun 17 — IV 13561% · EM ±566.3%Jun 19 — IV 2766% · EM ±611.2%Jun 22 — IV 2997% · EM ±625.9%Jun 23 — IV 2721% · EM ±556.6%Jun 24 — IV 3218% · EM ±644.5%Jun 25 — IV 3430% · EM ±671.8%Jun 26 — IV 3483% · EM ±666.7%Jun 29 — IV 3795% · EM ±672.4%Jun 30 — IV 4541% · EM ±782.0%Jul 01 — IV 4426% · EM ±739.4%Jul 02 — IV 4570% · EM ±739.2%Jul 03 — IV 4730% · EM ±739.2%Jul 06 — IV 5639% · EM ±781.1%Jul 07 — IV 6783% · EM ±895.8%Jul 08 — IV 6893% · EM ±863.6%Jul 09 — IV 7576% · EM ±894.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in